Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome. Authors' reply

Vivek C Goodoory^{1

2}, Cho Ee Ng³, Christopher J Black^{1

2}, Alexander C Ford^{1

2}

Affiliations

¹ Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.
² Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.
³ County Durham and Darlington NHS Foundation Trust, Durham, UK.

Editorial

Vivek C Goodoory et al. Aliment Pharmacol Ther. 2022 Sep.

. 2022 Sep;56(5):894-895.

doi: 10.1111/apt.17160.

Vivek C Goodoory^{1

2}, Cho Ee Ng³, Christopher J Black^{1

2}, Alexander C Ford^{1

2}

¹ Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.
² Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.
³ County Durham and Darlington NHS Foundation Trust, Durham, UK.

No abstract available

Comment on

Impact of Rome IV irritable bowel syndrome on work and activities of daily living.
Goodoory VC, Ng CE, Black CJ, Ford AC. Goodoory VC, et al. Aliment Pharmacol Ther. 2022 Sep;56(5):844-856. doi: 10.1111/apt.17132. Epub 2022 Jul 6. Aliment Pharmacol Ther. 2022. PMID: 35794733 Free PMC article.
Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome.
Shah ED, Wechsler EV. Shah ED, et al. Aliment Pharmacol Ther. 2022 Sep;56(5):892-893. doi: 10.1111/apt.17143. Aliment Pharmacol Ther. 2022. PMID: 35934848 No abstract available.

1. Shah ED, Wechsler EV. Editorial: work and activity impairment are important considerations to optimize treatment plans for irritable bowel syndrome. Aliment Pharmacol Ther. 2022;56:892-893.
1. Goodoory VC, Ng CE, Black CJ, Ford AC. Impact of Rome IV irritable bowel syndrome on work and activities of daily living. Aliment Pharmacol Ther. 2022;56:844-856.
1. Black CJ, Burr NE, Camilleri M, Earnest DL, Quigley EM, Moayyedi P, et al. Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis. Gut. 2020;69(1):74-82.
1. Black CJ, Burr NE, Quigley EMM, Moayyedi P, Houghton LA, Ford AC. Efficacy of secretagogues in patients with irritable bowel syndrome with constipation: systematic review and network meta-analysis. Gastroenterol. 2018;155(6):1753-63.
1. Black CJ, Staudacher HM, Ford AC. Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut. 2022;71:1117-26.